Egle Therapeutics
Biotherapies developer targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases.
Name
# Contributions
Last Contribution
Find more companies like Egle Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.